Ymir Genomics is a biotechnology startup dedicated to finding biomarkers for diagnostics and therapeutics. The company’s main focus is the discovery of easily assayable circulating RNA biomarkers found in biofluids such as blood, saliva, and urine.
Ymir has developed a novel proprietary protocol for isolating exosomal RNA and proteins from several biofluids. Its method is two- to 10-times more efficient than current commercial kits and offers a substantial savings on time and cost. Ymir is currently optimizing its exosome isolation protocol towards commercialization. In parallel, the company is using this method and a novel bioinformatics protocol to find urine biomarkers for prostate and bladder cancer.
Company Details
- Founded
- -
- Address
- Labcentral, Cambridge,ma,united States
- co****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ymirgenomics.com
- HQ
- Cambridge, MA
Ymir Genomics Questions
Ymir Genomics's website is ymirgenomics.com
Ymir Genomics's LinkedIn profile is https://www.linkedin.com/company/ymir-genomics
Ymir Genomics's industry is
Biotechnology Research
Ymir Genomics's top competitors are
Carlbio Pvt Ltd,
Trimontia Genomics, Inc. | Ucla/david Geffen School Of Medicine,
Bioalg Corp.,
Genesis Laboratories,
Murrieta Genomics,
Evolvion - Student Association,
Just-Dna-Seq,
Propionic Acidemia Foundation,
Genlab Biosolutions Private Limited,
Seneca Creek Research.
Ymir Genomics's support email address is contact@ymirgenomics.com
Ymir Genomics's categories are Biotechnology Research
Ymir Genomics's founding year is 2011
